We attempted to elicit active anaphylaxis to ovalbumin, or passive IgE-or IgG 1 -dependent anaphylaxis, in mice lacking either the Fc ⑀ RI ␣ chain or the FcR ␥ chain common to 
Introduction
IgE-dependent mast cell activation has long been regarded as one of the essential steps in the development of the bronchoconstriction and other physiological changes associated with active anaphylaxis (1, 2) . This hypothesis not only is consistent with clinical observations (1, 2) , but has been supported by certain animal studies. For example, the adoptive transfer of IgE antibodies to normal mice (but not to genetically mast cell-deficient mice) primes these animals to express passive systemic anaphylactic reactions to intravenous challenge with specific antigen, and these responses are associated with extensive mast cell degranulation, marked alterations in cardiopulmonary function, and considerable mortality (3) . Thus, IgE-dependent mast cell activation can indeed produce many of the pathophysiological changes that are associated with active anaphylaxis (3, 4) .
However, several recent findings have called into question the essential role of mast cells or IgE antibodies in murine active anaphylactic responses. Genetically mast cell-deficient WBB6F 1 (5, 6) , as well as with mortality rates that are similar to those observed in the identically sensitized and challenged congenic ϩ / ϩ normal mice (5) (6) (7) (8) (9) . Moreover, IgE null mice also can express fatal active anaphylaxis responses that are associated with striking airway responses (10) . Thus, neither mast cells nor IgE antibodies are essential for the expression of at least some of the features of active systemic anaphylaxis in mice.
Sensitization of mice for active anaphylaxis not only induces an IgE response, but also results in the production of antigen-specific IgG 1 antibodies (11, 12) . Furthermore, IgG antibodies of the IgG 1 isotype, as well as IgE antibodies, can elicit both passive cutaneous anaphylactic reactions (13) and passive systemic anaphylactic responses (14) (15) (16) in mice. And it has been shown recently that IgG 1 antibodies can also passively sensitize mice for the expression of airway hyperresponsiveness to electrical stimulation in vitro, and for the development of increased numbers of eosinophils and other leukocytes in bronchoalveolar lavage fluid after allergen challenge of the airways in vivo (17) . Therefore, we investigated the hypothesis that IgG 1 antibodies and Fc ␥ R, rather than IgE antibodies and Fc ⑀ RI, can be critical for the expression of the cardiopulmonary changes and mortality associated with active systemic anaphylaxis in mice.
To assess the relative importance of IgE and Fc ⑀ RI versus IgG 1 and Fc ␥ R in the pathogenesis of active anaphylaxis in mice, we used mice with targeted mutations of either the Fc ⑀ RI ␣ chain of the Fc ⑀ RI (18) or the common ␥ chain of the Fc ⑀ RI and the Fc ␥ RI/III (19) . The Fc ⑀ RI consists of a single Fc ⑀ RI ␣ chain, a single ␤ chain, and two disulfide-linked ␥ chains (18, 20, 21) . The Fc ⑀ RI ␣ chain binds the Fc portion of IgE, whereas the ␤ chain promotes the assembly and cell surface expression of the Fc ⑀ RI and also helps to amplify signal transduction through the Fc ⑀ RI receptor's two ␥ chains (20) (21) (22) . Mice with targeted disruption of the gene encoding the Fc ⑀ RI ␣ chain (Fc ⑀ RI ␣ chain Ϫ / Ϫ mice) have normal numbers of tissue mast cells, but do not express Fc ⑀ RI and do not exhibit detectable increases in vascular permeability when examined for expression of IgE-dependent passive cutaneous or systemic anaphylactic responses (18) . However, until this study, the ability of Fc ⑀ RI ␣ chain Ϫ / Ϫ mice to express active systemic anaphylaxis, or IgG 1 -dependent passive systemic anaphylaxis, had not been investigated.
IgG antibodies can bind to three Fc ␥ Rs, two of which (Fc ␥ RI and Fc ␥ RIII) share the same ␥ chain as the Fc ⑀ RI (19, 20) . Fc ␥ RI, which consists of an Fc ⑀ RI ␣ chain and two ␥ chains, is a high-affinity IgG receptor that binds monomeric IgG (preferentially, IgG 2a ). It is expressed on macrophages and neutrophils and mediates phagocytosis and antibody-dependent cellular cytotoxicity (23, 24) . Mouse Fc ␥ RII and Fc ␥ RIII are low-affinity receptors that bind multimeric IgG (in decreasing order of affinity: IgG 2b Ͼ IgG 2a Ͼ IgG 1 ) (20, 24) . Fc ␥ RII is a single chain receptor expressed on B cells, T cells, and mast cells, on which it acts as an inhibitory receptor (25) (26) (27) . By contrast, Fc ␥ RIII is present on macrophages, neutrophils, and natural killer cells, where it can trigger antibody-dependent cellular cytotoxicity, endocytosis, exocytosis, and release of inflammatory mediators, and on mast cells, where it can trigger degranulation (28) .
Mice with targeted mutation of the gene encoding the ␥ chain of the Fc ⑀ RI and Fc ␥ RI/III (FcR ␥ chain Ϫ / Ϫ mice) develop normal numbers of tissue mast cells but express neither Fc ⑀ RI nor Fc ␥ RI/III (19) . Accordingly, Fc ␥ R Ϫ / Ϫ mice fail to develop local changes in cutaneous vascular permeability (i.e., passive cutaneous anaphylaxis responses) upon challenge with IgE and specific antigen (19) . However, until this study, the ability of FcR ␥ chain Ϫ / Ϫ mice to express active systemic anaphylaxis, or IgG 1 -dependent passive systemic anaphylaxis, had not been investigated.
In this study, we analyzed the ability of Fc ⑀ RI ␣ chain Ϫ / Ϫ or FcR ␥ chain Ϫ / Ϫ mice, and the corresponding normal mice, to express either active systemic anaphylaxis, or passive IgEor IgG 1 -dependent systemic anaphylaxis, as assessed by the extent of mast cell degranulation, the characteristics of the cardiopulmonary responses, and the death rates associated with these responses. We also attempted to elicit and characterize these three forms of systemic anaphylaxis in genetically mast cell-deficient WBB6F 1 -Kit W /Kit W-v mice and the congenic normal (WBB6F 1 -ϩ/ϩ) mice. The results show that IgE, Fc ⑀ RI, and/or mast cells may contribute to some of the pathophysiology of active systemic anaphylactic responses in the mouse, but that the mortality associated with active anaphylaxis is dependent on the FcR ␥ chain but not the Fc ⑀ RI. The results also strongly suggest that the mortality associated with active anaphylaxis in the mouse is mediated primarily by IgG 1 antibodies and Fc␥RIII.
Methods

Animals
The production of mice with targeted mutations that result in failure of production of the ␣ chain of the Fc ⑀ RI (Fc ⑀ RI ␣ chain Ϫ/Ϫ mice) (18) or the FcR ␥ chain (FcR ␥ chain Ϫ/Ϫ mice) (19) , and many of the phenotypic characteristics of these mice, have been described in detail. For these studies, we used male and female Fc ⑀ RI ␣ chain Ϫ/Ϫ mice (18) that were backcrossed for three generations with BALB/c mice, and used BALB/c mice (purchased from Jackson Biological Laboratory, Bar Harbor, ME) as Fc ⑀ RI ␣ chain ϩ/ϩ mice. Male and female FcR ␥ chain Ϫ/Ϫ and ϩ/ϩ mice were generated by breeding the F 2 offspring of crosses between chimeras and C57BL/6 mice (19 (29) (30) (31) , and the congenic normal (WBB6F 1 -ϩ/ϩ) male mice, were purchased from the Jackson Biological Laboratory. All mice were 9-23 wk old (18-40 g body wt) at the time of antigen challenge (see below, Protocols). In the individual experiments (testing one of the three models of systemic anaphylaxis in the various mutant mice and the corresponding wild-type mice) the mice in the four groups (experimental and control groups of mutant and wild-type animals) varied in mean age by a maximum of 8-34% and in mean body weight by a maximum of 3-28%.
The animal experiments were conducted in accordance with the Beth Israel Hospital's Institutional Animal Care and Use Committee and with guidelines prepared by the Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council (DHHS Publication No. 86-23, revised 1985). All mice were housed in microisolator cages in facilities supplied with high efficiency particulate-free air. Selected ("sentinel") mice in each room were sampled quarterly (approximately every 3 mo) and were found to be disease-free based on microbiological, parasitological, serological, and pathological examination. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] human serum albumin (DNP-HSA), propranolol, and ovalbumin (OVA) 1 were purchased from Sigma Chemical Co. (St. Louis, MO). We also purchased pentobarbital sodium (Anthony Products Co., Arcadia, CA), aluminum potassium sulfate (Fisher Scientific, Pittsburgh, PA), and Bordetella pertussis toxin (List Biological Laboratories, Inc., Campbell, CA).
Reagents
Physiological measurements
Heart rate (HR) and the pulmonary mechanical parameters, dynamic compliance (C dyn ), and lung conductance (G L ), were measured in mice anesthetized with 70-90 mg/kg i.p. of sodium pentobarbital using a plethysmographic method (4, 5, 34) . C dyn and pulmonary resistance were calculated from the recordings of volume, flow, and pressure using standard techniques (35) . Baseline values of HR, C dyn , and G L were determined 10-20 min after preparation of the animals for recording pulmonary parameters. Baseline values for HR, C dyn , and G L in the six groups of mice tested were similar to those previously reported for WCB6F 1 -ϩ/ϩ mice (2), with only minor differences between values for the mutant and the corresponding wild-type mice (Table I) .
After establishing baseline levels of physiological parameters, mice were then challenged with antigen as described below (Protocols) for assessment of anaphylactic reactions, and HR, C dyn , and G L were measured at multiple intervals until death due to antigen challenge or, after a period of 40 or 60 min, cervical dislocation. Changes in physiological measurements over time are expressed as a percentage of the corresponding baseline value (which was taken as 100%). Time of death was estimated as that time at which no spontaneous respiratory activity was detected when the ventilator was shut off (approximately every 5 min beginning 20 min after antigen challenge). All of the physiological experiments were performed by a single investigator (I. Miyajima).
1. Abbreviations used in this paper: C dyn , dynamic compliance; G L , lung conductance; HR, heart rate; OVA, ovalbumin.
Histologic studies
The presence of tissue mast cells and their state of activation were assessed in 1-m, Epon-embedded, Giemsa-stained sections (4, 36, 37) . Tissues were removed and fixed as described previously (5, 36, 37) , either immediately after death induced by antigen (OVA or DNP-HSA) challenge, or after death by cervical dislocation 40-60 min after challenge. Sections of ear skin dermis (5, 37), peribronchial tissues (4, 5) , and forestomach (2) were evaluated for mast cell numbers and extent of mast cell degranulation, as described previously. Sections were coded so that the observer (I. Miyajima) was not aware of the identity of individual specimens, and examined at a magnification of 400 by light microscopy. Mast cells were classified as "extensively degranulated" (Ͼ 50% of the cytoplasmic granules exhibiting fusion, staining alterations, and/or extrusion from the cell), "moderately degranulated" (10-50% of the granules exhibiting fusion or discharge), or "normal" (5, 36, 37) . Our assessment of mast cell numbers in dermis of ear skin, peribronchial tissues, and forestomach confirmed the previous reports that the Fc ⑀ RI ␣ chain Ϫ/Ϫ (18) and FcR ␥ chain Ϫ/Ϫ (19) mice exhibit essentially normal numbers of tissue mast cells (data not shown).
Protocols
Sensitization for active systemic anaphylaxis to OVA. Mice received a single intraperitoneal injection of 0.1 ml of sterile, pyrogen-free 0.9% NaCl containing 100 g of OVA, 300 ng of Bordetella pertussis toxin, and 1.0 mg of aluminum potassium sulfate. Control (sham-immunized) mice received a single intraperitoneal injection of 0.1 ml of the same solution except for the omission of OVA. 18-21 d after OVA or sham immunization, mice were prepared for physiological measurements (see above) and were challenged by a rapid intravenous infusion (via an indwelling jugular vein catheter) of 500 g of OVA in ‫ف‬ 50 l of sterile, pyrogen-free 0.9% NaCl. Approximately 100 l of tail vein blood was obtained from mice placed under light ether anesthesia on the day before OVA or sham immunization (day Ϫ1) and on the day before antigen challenge (days [17] [18] [19] [20] , and the serum was stored at Ϫ80ЊC before assay for total IgE and IgG using ELISA assays as described in the companion manuscript (38).
Sensitization for IgE-or IgG 1 -dependent passive systemic anaphylaxis. Mouse monoclonal IgE anti-DNP antibodies ‫ف(‬ 20 g, as a 1:20 dilution of ascites in sterile, pyrogen-free 0.9% NaCl) or mouse monoclonal IgG 1 anti-DNP antibodies ‫ف(‬ 400 g, as a 1:4 dilution of ascites in sterile, pyrogen-free 0.9% NaCl) were administered intravenously by tail vein in volumes of ‫ف‬ 0.1 ml/mouse. Control mice for the IgEinduced passive anaphylaxis experiments received, instead of IgE anti-DNP antibodies, the same volume of 0.9% NaCl; controls for IgG 1 -induced passive anaphylaxis experiments received, instead of IgG 1 anti-DNP antibodies, 400 g of normal mouse IgG in the same volume of 0.9% NaCl. 1 d ‫ف(‬ 20-30 h) after passive sensitization (or control injections), the mice were prepared for physiological measurements (see above) and then challenged by a rapid intravenous infusion (via an indwelling jugular vein catheter) of ‫ف‬ 50 l of sterile, pyrogen-free 0.9% NaCl containing either 200 g of DNP-HSA (for experiments assessing IgE-induced passive systemic anaphylaxis) or 1.0 mg of DNP-HSA (for experiments assessing IgG 1 -induced passive systemic anaphylaxis). We selected the quantities of IgE or IgG 1 monoclonal antibodies to use for passive sensitization and the amounts of DNP-HSA to use for challenge based on preliminary dose-response experiments which showed that the chosen amounts of IgE antibodies and DNP-HSA produced fatal anaphylactic responses in the majority of normal mice tested for cardiopulmonary responses to challenge with IgE and specific antigen (Miyajima, I., and S.J. Galli, unpublished data), and on dose-response experiments which showed that the chosen amounts of IgG 1 antibodies and DNP-HSA produced marked drops in body temperature in normal mice (see the companion study, reference 38).
Statistical analysis
Differences among the various groups of mice in the time courses of HR, C dyn , or G L responses were examined for statistical significance by ANOVA. Differences in the maximum diminution in C dyn or G L , or the maximum HR responses, and differences in the numbers of mast cells in the tissues of different groups of mice were examined by the Student's t test (two-tailed). Differences in the extent of mast cell degranulation in various groups of mice were examined for statistical significance by the 2 test. Differences in the death rates between different experimental groups were examined for statistical significance by Fisher's exact test. Differences in the serum concentrations of total IgE or IgG 1 in the different experimental groups in experiments assessing active anaphylaxis were examined for statistical significance by the Mann-Whitney U test, two-tailed. P Ͻ 0.05 was regarded as significant. Unless otherwise specified, results are expressed as the meanϮSEM.
Results
Active systemic anaphylaxis is expressed in Fc
, antigen (OVA) challenge induced an active anaphylaxis response which was associated with the rapid development of tachycardia, diminished G L , and reduced C dyn (Fig. 1) . Antigen-challenged, OVA-sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice developed a tachycardia response that was similar in magnitude to that in the identically sensitized and challenged Fc ⑀ RI ␣ chain ϩ/ϩ mice, but which was somewhat more prolonged in duration ( Fig. 1 A) . In addition, in comparison to the responses in OVA-sensitized Fc ⑀ RI ␣ chain ϩ/ϩ mice, antigen challenge of OVA-sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice produced a more prolonged reduction in G L , as well as a significantly greater reduction in C dyn ( Fig. 1 A) . The differences in the physiological responses of the Fc ⑀ RI ␣ chain Ϫ/Ϫ versus ϩ/ϩ mice are not likely to have reflected differences in the size, age, or gender distribution of the mice expressing active anaphylaxis. Thus, we analyzed active anaphylaxis in four male and two female Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, of 13.8Ϯ1.6 wk of age [meanϮSEM] and 29.8Ϯ0.8 g body weight, versus six male and three female Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, of 15.9Ϯ1.8 wk of age and 29.1Ϯ1.3 g body weight. Note that in OVA-sensitized mice of either Fc ⑀ RI ␣ chain ϩ/ϩ or Ϫ/Ϫ genotype, the changes in HR reached maximal levels within 5 min of antigen challenge, and that the initial rapid declines in G L and C dyn also occurred within this same time frame.
As assessed morphologically in 1-m, Epon-embedded, Giemsa-stained sections ( Fig. 2 A) , antigen challenge of OVAsensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice or ϩ/ϩ mice resulted in extensive degranulation of mast cells in the ear skin, peribronchial tissues, and forestomach, whereas virtually all of the mast cells in the corresponding tissues of OVA-challenged nonsensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice or ϩ/ϩ mice appeared normal (i.e., exhibited no morphological evidence of activation). Even though the OVA-sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice developed pulmonary changes upon antigen challenge that were significantly greater than those in the identically challenged OVA-sensitized wild-type mice, the extent of mast cell degranulation in the bronchial tissues and forestomach of the OVAsensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice was slightly, but significantly, less than that in the corresponding tissues of the OVAsensitized wild-type mice.
The death rates due to active anaphylaxis were statistically indistinguishable in OVA-sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice or ϩ/ϩ mice (Table II) . All but one of the sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ or ϩ/ϩ mice died, most of them within 30 min of antigen challenge, whereas none of the antigen-challenged nonsensitized mice of either genotype died (P Ͻ 0.01 for either comparison). Both Fc ⑀ RI ␣ chain Ϫ/Ϫ and ϩ/ϩ mice exhibited increased serum concentrations of total IgE after OVA immunization (day Ϫ1 vs. day 17-20 values of 0.77Ϯ0.70 vs. 6.41Ϯ6.17 g/ml [meanϮSD], P ϭ 0.006 for Fc ⑀ RI ␣ chain Ϫ/Ϫ mice and 0.68Ϯ0.52 vs. 1.70Ϯ1.57 g/ml, P ϭ 0.082 for Fc ⑀ RI ␣ chain ϩ/ϩ mice). By contrast, serum concentrations of total IgG antibodies exhibited only modest increases in OVAimmunized mice (17 or 57% increases over baseline [day Ϫ1] values, from 235Ϯ222 to 276Ϯ322 g/ml in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, and from 207Ϯ58 to 326Ϯ99 g/ml in the corresponding ϩ/ϩ mice, respectively). Table II. OVA-sensitized FcR ␥ chain ϩ/ϩ mice also rapidly developed tachycardia in response to intravenous antigen challenge ( Fig. 1 B) , and this response was similar in magnitude to that in the Fc ⑀ RI ␣ chain ϩ/ϩ mice (Fig. 1 A) . The OVA-sensitized FcR ␥ chain ϩ/ϩ mice also rapidly developed reductions in G L and C dyn after antigen challenge, but these responses were even more striking than those in the Fc ⑀ RI ␣ chain ϩ/ϩ (or Fc ⑀ RI ␣ chain Ϫ/Ϫ) mice (compare Fig. 1, A and B) , perhaps reflecting differences in the genetic backgrounds of the mice (BALB/c for the Fc ⑀ RI ␣ chain ϩ/ϩ mice, C57BL/6 ϫ 129 for the FcR ␥ chain ϩ/ϩ mice). However, by morphological analysis, the extent of mast cell degranulation in the ear skin, bronchial tissues, and forestomach of the OVA-sensitized FcR ␥ chain ϩ/ϩ mice (Fig. 2 B) was very similar to that in the corresponding tissues of the OVA-sensitized Fc ⑀ RI ␣ chain ϩ/ϩ mice (Fig. 2 A) .
All of the OVA-sensitized FcR ␥ chain ϩ/ϩ mice died within 20 min of intravenous antigen challenge (Table II) . By contrast, none of the antigen-challenged OVA-sensitized FcR ␥ chain Ϫ/Ϫ mice died (Table II) . The OVA-sensitized FcR ␥ chain Ϫ/Ϫ mice also developed little or no morphological evidence of mast cell degranulation as a result of OVA challenge (Fig. 2 B) , nor did these mice develop significant changes in HR, G L , or C dyn (Fig. 1 B) . Thus, by all of the criteria which we analyzed, FcR ␥ chain Ϫ/Ϫ mice were unable to express active anaphylaxis.
The lack of anaphylactic responsiveness in FcR ␥ chain Ϫ/Ϫ mice did not appear to reflect a defect in the ability of these mice to generate an IgE antibody response, in that serum concentrations of total IgE in OVA-immunized FcR ␥ chain Ϫ/Ϫ mice (31.9Ϯ14.9 g/ml, 10.4 times the baseline level, P ϭ 0.008) were even greater than those in the OVA-immunized FcR ␥ chain ϩ/ϩ mice (2.96Ϯ0.91 g/ml, 4.8 times the baseline level, P ϭ 0.016). However, FcR ␥ chain ϩ/ϩ mice exhibited a larger increase in serum concentrations of total IgG (to 474Ϯ313 g/ml, a 260% increase over baseline, P ϭ 0.016) than did the FcR ␥ chain Ϫ/Ϫ mice (to 520Ϯ236 g/ml, a 37% increase over baseline, P ϭ 0.22). To assess the anaphylactic responsiveness of Fc ⑀ RI ␣ chain Ϫ/Ϫ or FcR ␥ chain Ϫ/Ϫ mice after sensitization with known quantities of antibodies of defined isotype and antigenic specificity, we examined systemic anaphylactic reactions in mice which had been passively sensitized with mouse monoclonal anti-DNP IgE or IgG 1 antibodies.
IgG 1 -dependent passive systemic anaphylaxis is expressed in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, but is largely ablated in FcR ␥ chain Ϫ/Ϫ mice. When mice were passively sensitized with a monoclonal anti-DNP IgG 1 antibody and then challenged 1 d later with specific antigen, an anaphylactic reaction associated with significant mortality occurred in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice and corresponding ϩ/ϩ mice, as well as in FcR ␥ chain ϩ/ϩ mice, but not in FcR ␥ chain Ϫ/Ϫ mice (Table III) . All but 2 of the 15 deaths in IgG 1 -sensitized mice occurred within 30-40 min of antigen challenge.
We found that the physiological changes associated with IgG 1 -dependent passive systemic anaphylaxis responses (Fig.  3, A and B) were different from those observed in active anaphylaxis (Fig. 1, A and B) . Moreover, in comparison to the findings in mice which expressed OVA-induced active sys- Table III. temic anaphylaxis, the responses to IgG 1 and antigen were associated with little or no morphological evidence of mast cell degranulation (Fig. 4, A and B) .
In those IgG 1 -sensitized mice which expressed tachycardia in response to antigen challenge, the responses reached maximal levels at ‫ف‬ 10-15 min after antigen challenge, as opposed to within 5 min or less in the active anaphylactic responses. And challenge with IgG 1 and antigen induced gradual and rather modest declines in G L and C dyn , which lacked the rapid, sharp, and partially reversible early drop which developed in normal mice that expressed active systemic anaphylactic responses.
Even though the death rates due to IgG 1 -dependent anaphylaxis (Table III) , as well as the virtual lack of morphological evidence of mast cell degranulation associated with these responses (Fig. 4 A) , were very similar in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice and Fc ⑀ RI ␣ chain ϩ/ϩ mice, the Fc ⑀ RI ␣ chain Ϫ/Ϫ animals exhibited tachycardia responses and reductions in G L , that were significantly greater than those in the corresponding wild-type mice. These findings are reminiscent of those obtained in animals of the same genotype in the active anaphylactic responses (Fig. 1 A) . Moreover, the extent of mast cell degranulation in the bronchial tissues of IgG 1 -sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, while minimal and not significantly different than that in control Fc ⑀ RI ␣ chain Ϫ/Ϫ mice which had not been sensitized with IgG 1 , was significantly greater than that observed in the bronchial tissues of the identically sensitized and antigen-challenged Fc ⑀ RI ␣ chain ϩ/ϩ mice (Fig. 4 A) . As in the case of the active anaphylaxis responses in Fc ⑀ RI ␣ chain Ϫ/Ϫ and corresponding wild-type mice, the differences in the responses in the mutant and wild-type mice are not likely to have reflected differences in the age or gender distribution of the animals. Thus, we analyzed IgG 1 -dependent passive systemic anaphylaxis in five female Fc ⑀ RI ␣ chain ϩ/ϩ mice, of 14.8Ϯ0.5 wk of age, versus six female Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, all of ‫ف‬ 14 wk of age.
By contrast, IgG 1 -sensitized FcR ␥ chain Ϫ/Ϫ mice failed to develop statistically significant changes in G L or C dyn upon antigen challenge, whereas significant, albeit rather modest, pulmonary responses developed in the IgG 1 -sensitized FcR ␥ chain ϩ/ϩ mice (Fig. 3 B) . It may be of some interest, in this regard, that of the three anatomical sites analyzed in mice challenged with IgG 1 and antigen, the bronchial tissues were the only location where FcR ␥ chain ϩ/ϩ mice exhibited significantly more mast cell degranulation than did the FcR ␥ chain Ϫ/Ϫ mice (Fig. 4 B) . Note, however, that both FcR ␥ chain ϩ/ϩ mice and FcR ␥ chain Ϫ/Ϫ mice developed a tachycardia response in response to IgG 1 sensitization and antigen challenge. Furthermore, even though all of the FcR ␥ chain Ϫ/Ϫ mice which had been sensitized with IgG 1 anti-DNP antibodies survived intravenous challenge with DNP-HSA (Table III) , they exhibited roughly the same modest levels of mast cell activation in the ear skin and forestomach as did the identically sensitized and challenged FcR ␥ chain ϩ/ϩ mice (Fig. 4 B) .
IgE-dependent passive systemic anaphylaxis requires the Fc ⑀ RI ␣ chain and FcR ␥ chain and is associated with cardiopulmonary responses that mimic those in active anaphylaxis.
While tachycardia and declines in G L and/or C dyn occurred during IgG 1 -dependent passive systemic anaphylaxis (Fig. 3, A  and B) , these changes developed more slowly than in active systemic anaphylaxis (Fig. 1, A and B) , and the responses were associated with much lower levels of mast cell degranulation (compare Figs. 2 and 4) . Therefore, we investigated whether the features of IgE-dependent passive systemic anaphylaxis might more closely resemble those of the active anaphylactic responses than did the characteristics of the IgG 1 -dependent reactions. Both Fc ⑀ RI ␣ chain ϩ/ϩ mice (Fig. 5 A) and, to an even greater extent, FcR ␥ chain ϩ/ϩ mice (Fig. 5 B) developed tachycardia responses, as well as decreased C dyn and G L , in response to intravenous antigen challenge 1 d after passive sensitization with IgE antibodies. Like the physiological responses associated with active anaphylaxis, both the changes in HR and the initial changes in pulmonary function occurred rapidly after antigen challenge, and these responses, like the active anaphylactic reactions, were associated with morphological evidence of extensive mast cell degranulation (Fig. 6, A and B) . And, as in the case of the active anaphylactic responses (Table  II) , most of the IgE-sensitized Fc ⑀ RI ␣ chain ϩ/ϩ or FcR ␥ chain ϩ/ϩ mice died after antigen challenge (Table IV) . However, death due to IgE-dependent passive systemic anaphylaxis occurred somewhat later than that due to active anaphylaxis. Thus, all 10 of the mice which succumbed to IgE-dependent passive anaphylaxis died within 30-40 min of antigen challenge (Table IV) , whereas 15 of the 18 mice that developed fatal active anaphylaxis died within 20-25 min of antigen challenge (Table II) .
As expected, IgE-sensitized, antigen-challenged Fc ⑀ RI ␣ chain Ϫ/Ϫ mice or FcR ␥ chain Ϫ/Ϫ mice developed neither extensive mast cell degranulation (Fig. 6, A and B) nor significant cardiopulmonary changes (Fig. 5, A and B) , nor did these mice exhibit significant mortality (Table IV) .
Mast cells are not essential for the expression of active anaphylaxis or IgG 1 -dependent passive systemic anaphylaxis, but may enhance the intensity of these responses.
To assess the extent to which the cardiopulmonary changes and death associated with active systemic anaphylaxis to OVA, or IgG 1 -dependent passive systemic anaphylaxis to DNP-HSA, can be mast cell-independent, we attempted to elicit these responses in mast cell-deficient Kit W /Kit W-v mice and the congenic normal (Table V) .
However, the cardiopulmonary changes associated with ac- (Fig. 7 A) . WBB6F 1 -ϩ/ϩ mice exhibiting active anaphylaxis to OVA also developed extensive mast cell degranulation (Fig. 8 A) , to levels similar to those observed in association with OVA-induced active systemic anaphylaxis in the wild-type mice of the other genotypes tested (compare Fig. 2, A and B) .
When challenged for IgG 1 -induced passive systemic anaphylaxis, WBB6F 1 -ϩ/ϩ mice exhibited responses which in some respects were even stronger than those of FcR ␥ chain ϩ/ϩ mice (Figs. 3 B and 4 B) . The WBB6F 1 -ϩ/ϩ mice exhibited a strong tachycardia response, which peaked at ‫ف‬ 10 min, and developed substantial and significant declines in G L and C dyn . The mast cell degranulation which developed in these mice was also more extensive (Fig. 8 B) than that in FcR ␥ chain ϩ/ϩ mice which had been challenged for IgG 1 -dependent passive systemic anaphylaxis (Fig. 4 B) , but was less striking than that in WBB6F 1 -ϩ/ϩ mice which had been challenged for active anaphylaxis to OVA (compare Fig. 8 A) . Table V. tially weaker than those in the congenic ϩ/ϩ mice. Thus, the Kit W /Kit W-v mice developed tachycardia more slowly (and to lower maximum levels of HR) than the congenic ϩ/ϩ mice and developed only small declines in G L and C dyn . Furthermore, only one out of six Kit W /Kit W-v died as a result of IgG 1 -dependent passive anaphylaxis, as opposed to five out of six of the congenic ϩ/ϩ mice (Table V) .
In confirmation of our previous findings (4, 5), WBB6F 1 -ϩ/ϩ mice challenged for IgE-dependent systemic anaphylaxis to DNP-HSA developed strong responses, associated with a rapid elevation of HR, rapid, large, and partially reversible drops in G L and C dyn , and extensive mast cell degranulation, whereas the Kit W /Kit W-v mice gave no detectable responses (data not shown). Five out of six WBB6F 1 -ϩ/ϩ mice challenged for IgE-dependent systemic anaphylaxis died (at 40-60 min after antigen challenge) versus zero out of four antigenchallenged control ϩ/ϩ mice which had been injected with vehicle instead of IgE (P Ͻ 0.01 by Fisher's exact test Table VI summarizes the characteristics of the physiological responses, mast cell degranulation, and death rates associated with the three types of anaphylactic reactions in the Fc ⑀ RI ␣ chain Ϫ/Ϫ and corresponding ϩ/ϩ mice, the FcR ␥ chain Ϫ/Ϫ and corresponding ϩ/ϩ mice, and the mast cell-deficient Kit W / Kit W-v and congenic ϩ/ϩ mice. The table does not summarize the intensity of the cardiopulmonary responses in the mice of each genotype, as all of the key conclusions of our study are based on comparisons of responses of mutant and corresponding wild-type mice of the same genetic backgrounds. However, the figures depicting the cardiopulmonary responses illustrate differences in the intensity of the responses in wild-type mice of different genetic backgrounds, generally in the order WBB6F 1 Ͼ FcR ␥ chain ϩ/ϩ (C57BL/6 ϫ 129) Ͼ Fc ⑀ RI ␣ chain ϩ/ϩ (BALB/c). These differences, and perhaps also the differences in the extent of mast cell degranulation among the various wild-type mice, may be related to the differences in the genetic backgrounds of these animals.
Discussion
In the models tested, mice devoid of only Fc ⑀ RI, or lacking both Fc ⑀ RI and Fc␥RI/III, exhibited very distinct patterns of defects in their ability to express active systemic anaphylaxis or IgE-or IgG 1 -dependent passive systemic anaphylaxis. Fc ⑀ RI ␣ chain Ϫ/Ϫ mice that lacked Fc ⑀ RI nonetheless expressed active systemic anaphylactic responses that were associated with extensive mast cell degranulation and a high mortality rate. These results indicate that even though IgE-dependent mast cell degranulation can result in the expression of fatal passive systemic anaphylactic responses that are associated with significant cardiopulmonary changes (references 4 and 5 and Table  VI) , a functional Fc ⑀ RI is not required for either the mast cell degranulation or the mortality associated with active systemic anaphylaxis.
Indeed, the cardiopulmonary changes associated with active systemic anaphylactic reactions in the Fc ⑀ RI ␣ chain Ϫ/Ϫ mice were even more intense and/or more prolonged than those in the corresponding wild-type mice. In vitro findings indicate that, in the absence of the Fc ⑀ RI ␣ chain, mast cells can exhibit increased expression of Fc␥RIII (see companion study, reference 38). Accordingly, one possible explanation for the increased magnitude and/or duration of cardiopulmonary responses during active systemic anaphylaxis in Fc ⑀ RI ␣ chain Ϫ/Ϫ versus the corresponding ϩ/ϩ mice is that the Fc ⑀ RI ␣ chain Ϫ/Ϫ mice exhibited increased levels of Fc␥RIII-dependent mast cell signaling and mediator production. However, if this indeed occurred during our experiments, it was not reflected in higher levels of mast cell degranulation in the tissues of Fc ⑀ RI ␣ chain Ϫ/Ϫ versus corresponding wild-type mice, at least as could be assessed by histological analysis. Alternatively, the Fc ⑀ RI ␣ chain Ϫ/Ϫ and corresponding ϩ/ϩ mice may have differed in some other aspect(s) of their response to active immunization and/or antigen challenge which affected the intensity of their physiological responses. However, whatever the explanation for the more severe cardiopulmonary changes associated with active anaphylaxis in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in the corresponding wild-type mice, the results clearly illustrate that the physiological changes, as well as the death, associated with active systemic anaphylaxis can occur in the complete absence of the Fc ⑀ RI ␣ chain.
In contrast to their ability to express all of the features of active systemic anaphylaxis reactions that we analyzed, Fc ⑀ RI ␣ chain Ϫ/Ϫ mice completely lacked the ability to express IgEdependent passive systemic anaphylactic responses, whether judged by histological evidence of mast cell degranulation, the development of cardiopulmonary changes, or mortality. These findings are fully consistent with the observation that Fc ⑀ RI ␣ chain null mice also fail to develop either the augmented vascular permeability, or the marked drop in body temperature, associated with these responses (18) , and indicate that most, and perhaps all, of the pathophysiology of IgE-dependent anaphylactic responses occur by Fc ⑀ RI-dependent mechanisms, rather than by interactions between IgE and Fc␥RII/III or other receptors that can interact with IgE (39) .
Unlike mice that had a selective deficiency of Fc ⑀ RI, mice that lacked the FcR ␥ subunit were profoundly deficient in their ability to express all three types of systemic anaphylactic responses. FcR ␥ chain Ϫ/Ϫ mice exhibited no detectable active systemic anaphylactic responses or IgE-dependent passive anaphylactic reactions, whether these responses were assessed by cardiopulmonary changes, mast cell degranulation, or mortality. These latter results are consistent with the observations that FcR ␥ chain Ϫ/Ϫ mice failed to express detectable IgEdependent passive cutaneous anaphylaxis responses in vivo, or significant IgE-dependent mast cell degranulation in vitro (19) . However, the findings in this study are the first to indicate that all (or virtually all) of the cardiopulmonary changes, and the mortality, associated with either IgE-dependent passive systemic anaphylaxis or active systemic anaphylaxis in mice also require the signal transduction function of the FcR ␥ chain.
The FcR ␥ chain represents a component of both Fc␥RI and Fc␥RIII. We found that IgG 1 antibodies, which bind much more preferentially to Fc␥RIII than to Fc␥RI (23), can sensitize Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, Fc ⑀ RI ␣ chain ϩ/ϩ mice, or FcR ␥ chain ϩ/ϩ mice, but not FcR ␥ chain Ϫ/Ϫ mice, for passive systemic anaphylaxis responses. Thus, while we have not formally ruled out the possibility that Fc␥RI contribute to active anaphylaxis in mice, it appears likely that Fc␥RIII, not Fc␥RI, are critical for the expression of this response. Additional, and more direct, evidence supporting this conclusion is presented in the companion study (38). Further support for the hypothesis that it is Fc␥RIII, not Fc␥RI, which are critical for the mast cell degranulation and perhaps other components of the pathogenesis of IgG 1 -dependent systemic anaphylactic response has been provided by a report of the generation and initial characterization of Fc␥RIII ␣ chain Ϫ/Ϫ mice (40) , which appeared while the present manuscript was in review. Fc␥RIII ␣ chain Ϫ/Ϫ mice, unlike the corresponding wild-type mice, failed to exhibit IgG-dependent peritoneal mast cell degranulation in vitro or IgG-dependent passive cutaneous anaphylaxis (as assessed by extravasation of Evan's blue dye into the ear skin) in vivo (40) . However, the ability of such mice to express active or passive systemic anaphylactic reactions was not examined (40) .
Given the potential complexity of the pathogenesis of active anaphylactic responses, it is perhaps not surprising that the features of the IgG 1 -dependent passive systemic anaphylactic responses and active anaphylactic reactions which we studied were not fully identical. Although the IgG 1 -dependent reactions were associated with a high mortality rate, the tachycardia observed in these responses developed much more slowly than in IgE-dependent passive, or OVA-induced active, systemic anaphylactic responses. Moreover, G L and C dyn diminished very gradually during the passive, IgG 1 -dependent responses, without the rapid and partially reversible early reductions noted in the active or IgE-dependent passive responses. Ϫ, not statistically significant at P Ͻ 0.05 at any site vs. values for control (nonsensitized) mice, and Ͻ 25% extensive or moderate degranulation in all three sites. ϩ, statistically significant at P Ͻ 0.001 in two sites vs. values for control (nonsensitized) mice, and 25-50% extensive or moderate degranulation in two or three sites. ϩϩ, statistically significant at P Ͻ 0.001 at all sites vs. values for control (nonsensitized) mice, and Ͼ 50% extensive or moderate degranulation in two or three sites. ϩϩϩ, statistically significant at P Ͻ 0.001 at all sites vs. values for control (nonsensitized) mice, and Ͼ 80% extensive or moderate degranulation in two or three sites. DNA, does not apply (no mast cells present).
Immunization for active anaphylaxis may have been associated with many changes (e.g., in levels of antigen-specific immunoglobulins of different isotypes, numbers of various effector cells, levels of FcR expression by these cells, and local concentrations of immunomodulatory cytokines) which were not mimicked in mice that had been passively sensitized with IgG 1 antibodies. Thus, it may be quite difficult to ascertain the reason(s) for the observed differences in the physiological changes associated with antigen challenge in animals sensitized for active as opposed to passive, IgG 1 -dependent anaphylaxis. It is possible that some of these differences are related to the much more modest levels of mast cell activation that were observed in association with the IgG 1 -dependent passive responses, as opposed to the active or passive IgE-dependent reactions. However, it has been demonstrated already that significant pulmonary changes (4, 5) , and death (4, 5, (7) (8) (9) , can occur during active anaphylactic responses which are elicited in the virtual absence of mast cells.
These observations, as well as the results of our histological analysis (Fig. 4 A) , suggest that the pulmonary changes which develop during IgG 1 -dependent passive anaphylaxis can also occur independently of any critical contribution of the mast cell. On the other hand, the cardiopulmonary changes associated with IgG 1 -dependent passive systemic anaphylaxis, as well as the mortality associated with this response, were greater in WBB6F 1 -ϩ/ϩ (normal) mice than in the congenic mast cell-deficient WBB6F 1 (Fig. 7 B) . These findings suggest that IgG 1 -dependent mast cell degranulation can, under some circumstances, contribute to the intensity of IgG 1 -dependent passive systemic anaphylactic responses.
When taken together, do our results (and those presented in the companion study, reference 38) prove that the pathophysiology of active anaphylaxis in mice is solely dependent on signaling mediated by the FcR ␥ chain? Not at all. While FcR ␥ chain Ϫ/Ϫ mice completely failed to express active anaphylaxis to OVA challenge and exhibited neither mortality nor pulmonary changes in response to challenge with IgG 1 antibodies and specific antigen, IgG 1 -sensitized FcR ␥ chain Ϫ/Ϫ mice did express a statistically significant tachycardia response upon antigen challenge (Fig. 3 B) . Moreover, these FcR ␥ chain Ϫ/Ϫ mice also developed modest, but statistically significant, levels of mast cell degranulation in the ear skin and forestomach, responses that were statistically indistinguishable from those in the IgG 1 -sensitized and antigen-challenged FcR ␥ chain ϩ/ϩ mice (Fig. 4 B) .
These results indicate that sensitization with IgG 1 and challenge with specific antigen can induce both tachycardia responses and small amounts of mast cell degranulation independently of Fc␥RI/III-(or Fc ⑀ RI-) dependent signaling. Mast cells can be activated by anaphylatoxins (C3a, C5a), peptides that are generated as a result of complement activation (41) . Moreover, we have found that tachycardia is a much more sensitive indicator of mast cell-dependent passive systemic anaphylactic reactions than are changes in G L or C dyn or mortality (5, and Miyajima, I., and S.J. Galli, unpublished data). Accordingly, it is possible that the weak tachycardia response to antigen challenge in IgG 1 -injected FcR ␥ chain Ϫ/Ϫ mice reflected complement activation by anti-DNP IgG 1 -DNP-HSA immune complexes. Nevertheless, it should be emphasized that FcR ␥ chain Ϫ/Ϫ mice exhibited neither pulmonary changes nor increased mortality upon challenge with IgG 1 and specific antigen. Therefore, we can conclude that, no matter what IgG 1 -dependent but FcR-independent processes may have occurred in our experiments, the development of the most clinically significant consequences of IgG 1 -dependent passive anaphylaxis reactions required adequate signaling through the FcR ␥ chain.
If virtually all of the pathophysiology of both active and IgG 1 -dependent passive systemic anaphylaxis responses reflects the signaling function of the FcR ␥ chain, and if both active and IgG 1 -dependent passive systemic anaphylaxis responses can be expressed in mice that lack the Fc ⑀ RI, can we conclude that IgE and mast cells have no role in active anaphylaxis in the mouse? Again, not without qualification. Many of our findings, particularly those derived from analyses of mast cell-deficient Kit W /Kit W-v mice and the congenic normal mice, are consistent with the possibility that mast cell degranulation contributed to the rapid and partially reversible diminutions of G L and C dyn , and to the rapid onset of tachycardia, that typically occurred during the active or IgE-dependent passive systemic anaphylactic responses. In some circumstances (e.g., in WBB6F 1 -ϩ/ϩ mice), mast cell degranulation may also contribute to the intensity of the cardiopulmonary changes and mortality associated with IgG 1 -dependent passive systemic anaphylaxis. Mast cell degranulation during active anaphylaxis may have occurred primarily via IgE and Fc ⑀ RI in normal mice, but by IgG 1 -dependent mechanisms in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice that express increased levels of mast cell activation via Fc␥RIII (16, and see companion study [38] ). However, no matter what role IgE and/or mast cells played in active systemic anaphylaxis to OVA, the findings reported here, as well as previous work (4, 5, (7) (8) (9) (10) , indicate that neither IgE nor mast cells are required for the mortality associated with this reaction.
